ATRC Insider Sale: CTO Offloads $201K as Stock +49%
AtriCure's CTO sold $201,135 in stock at $55 per share as ATRC rallied 49% over 12 months. The 10b5-1 plan reduces negative signaling, but the sale raises valuation questions amid thin net margins.
Source: Jack Delaney (us) · fool.com